Ernest Asante-Appiah, Merck & Co., Inc

Merck & Co., Inc
Ernest is a research scientist in the Infectious Disease and Vaccines Department at Merck Research Laboratories. He was part of the team that discovered and developed doravirine, a novel NNRTI approved for HIV-1 treatment in adults.

Presenter Of 1 Presentation

 On-Demand Abstracts
Oral poster discussion session

PDB0406 - Doravirine resistance profile in clinical isolates and impact of baseline NNRTI resistance-associated mutations observed in treatment-naïve participants from phase 3 clinical trials

Speaker
Session Name
PDB04 - Resistance
Room
Abstract Sessions On-Demand Channel

Presenter Of 1 Presentation

 All On-demand Sessions
Oral poster discussion session

Doravirine resistance profile in clinical isolates and impact of baseline NNRTI resistance-associated mutations observed in treatment-naïve participants from phase 3 clinical trials

Speaker
Session Name
PDB04 - Resistance
Room
Abstract Sessions On-Demand Channel

Presenter Of 1 Presentation

 Overall Programme
Oral poster discussion session

Doravirine resistance profile in clinical isolates and impact of baseline NNRTI resistance-associated mutations observed in treatment-naïve participants from phase 3 clinical trials

Speaker
Session Name
PDB04 - Resistance
Room
Abstract Sessions On-Demand Channel